216 related articles for article (PubMed ID: 27497990)
21. Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.
Gama RL; Bruin VM; Távora DG; Duran FL; Bittencourt L; Tufik S
Brain Cogn; 2014 Jun; 87():97-103. PubMed ID: 24732953
[TBL] [Abstract][Full Text] [Related]
22. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study.
Gibson G; Mottram PG; Burn DJ; Hindle JV; Landau S; Samuel M; Hurt CS; Brown RG; M Wilson KC
Int J Geriatr Psychiatry; 2013 Jun; 28(6):626-31. PubMed ID: 22927195
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease.
Wang J; Si YM; Liu ZL; Yu L
Pharmacogenetics; 2003 Jun; 13(6):365-9. PubMed ID: 12777967
[TBL] [Abstract][Full Text] [Related]
24. Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease.
Sinclair L; Brenton J; Liu AKL; MacLachlan R; Gentleman SM; Love S
J Neuropsychiatry Clin Neurosci; 2022; 34(2):168-176. PubMed ID: 34961331
[TBL] [Abstract][Full Text] [Related]
25. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
de la Fuente-Fernández R; Núñez MA; López E
Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253
[TBL] [Abstract][Full Text] [Related]
26. Genetic Polymorphisms in
Dipanwita S; Arindam B; Atanu B; Kunal R; Jharna R
Neurol India; 2022; 70(2):729-732. PubMed ID: 35532648
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
28. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease.
Manganelli F; Vitale C; Santangelo G; Pisciotta C; Iodice R; Cozzolino A; Dubbioso R; Picillo M; Barone P; Santoro L
Brain; 2009 Sep; 132(Pt 9):2350-5. PubMed ID: 19584099
[TBL] [Abstract][Full Text] [Related]
29. Sleep patterns in Parkinson's disease patients with visual hallucinations.
Barnes J; Connelly V; Wiggs L; Boubert L; Maravic K
Int J Neurosci; 2010 Aug; 120(8):564-9. PubMed ID: 20615061
[TBL] [Abstract][Full Text] [Related]
30. Executive functions are impaired in patients with Parkinson's disease with visual hallucinations.
Barnes J; Boubert L
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):190-2. PubMed ID: 18202206
[TBL] [Abstract][Full Text] [Related]
31. Patient and Informant Views on Visual Hallucinations in Parkinson Disease.
Urwyler P; Nef T; Müri RM; Killen A; Collerton D; Burn D; McKeith I; Mosimann UP
Am J Geriatr Psychiatry; 2015 Sep; 23(9):970-6. PubMed ID: 25623941
[TBL] [Abstract][Full Text] [Related]
32. The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.
Geerligs L; Meppelink AM; Brouwer WH; van Laar T
Clin Neuropharmacol; 2009; 32(5):266-8. PubMed ID: 19667979
[TBL] [Abstract][Full Text] [Related]
33. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia.
Zhu F; Yan CX; Wang Q; Zhu YS; Zhao Y; Huang J; Zhang HB; Gao CG; Li SB
Brain Res; 2011 Oct; 1420():106-13. PubMed ID: 21955727
[TBL] [Abstract][Full Text] [Related]
34. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
[TBL] [Abstract][Full Text] [Related]
36. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
Pagonabarraga J; Martinez-Horta S; Fernández de Bobadilla R; Pérez J; Ribosa-Nogué R; Marín J; Pascual-Sedano B; García C; Gironell A; Kulisevsky J
Mov Disord; 2016 Jan; 31(1):45-52. PubMed ID: 26408291
[TBL] [Abstract][Full Text] [Related]
37. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
38. Reality monitoring and visual hallucinations in Parkinson's disease.
Barnes J; Boubert L; Harris J; Lee A; David AS
Neuropsychologia; 2003; 41(5):565-74. PubMed ID: 12559149
[TBL] [Abstract][Full Text] [Related]
39. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
40. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
